Membrane sweeping for induction of labour.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
27 02 2020
Historique:
entrez: 28 2 2020
pubmed: 28 2 2020
medline: 20 6 2020
Statut: epublish

Résumé

Induction of labour involves stimulating uterine contractions artificially to promote the onset of labour. There are several pharmacological, surgical and mechanical methods used to induce labour. Membrane sweeping is a mechanical technique whereby a clinician inserts one or two fingers into the cervix and using a continuous circular sweeping motion detaches the inferior pole of the membranes from the lower uterine segment. This produces hormones that encourage effacement and dilatation potentially promoting labour. This review is an update to a review first published in 2005. To assess the effects and safety of membrane sweeping for induction of labour in women at or near term (≥ 36 weeks' gestation). We searched Cochrane Pregnancy and Childbirth's Trials Register (25 February 2019), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (25 February 2019), and reference lists of retrieved studies. Randomised and quasi-randomised controlled trials comparing membrane sweeping used for third trimester cervical ripening or labour induction with placebo/no treatment or other methods listed on a predefined list of labour induction methods. Cluster-randomised trials were eligible, but none were identified. Two review authors independently assessed studies for inclusion, risk of bias and extracted data. Data were checked for accuracy. Disagreements were resolved by discussion, or by including a third review author. The certainty of the evidence was assessed using the GRADE approach. We included 44 studies (20 new to this update), reporting data for 6940 women and their infants. We used random-effects throughout. Overall, the risk of bias was assessed as low or unclear risk in most domains across studies. Evidence certainty, assessed using GRADE, was found to be generally low, mainly due to study design, inconsistency and imprecision. Six studies (n = 1284) compared membrane sweeping with more than one intervention and were thus included in more than one comparison. No trials reported on the outcomes uterine hyperstimulation with/without fetal heart rate (FHR) change, uterine rupture or neonatal encephalopathy. Forty studies (6548 participants) compared membrane sweeping with no treatment/sham Women randomised to membrane sweeping may be more likely to experience: · spontaneous onset of labour (average risk ratio (aRR) 1.21, 95% confidence interval (CI) 1.08 to 1.34, 17 studies, 3170 participants, low-certainty evidence). but less likely to experience: · induction (aRR 0.73, 95% CI 0.56 to 0.94, 16 studies, 3224 participants, low-certainty evidence); There may be little to no difference between groups for: · caesareans (aRR 0.94, 95% CI 0.85 to 1.04, 32 studies, 5499 participants, moderate-certainty evidence); · spontaneous vaginal birth (aRR 1.03, 95% CI 0.99 to 1.07, 26 studies, 4538 participants, moderate-certainty evidence); · maternal death or serious morbidity (aRR 0.83, 95% CI 0.57 to 1.20, 17 studies, 2749 participants, low-certainty evidence); · neonatal perinatal death or serious morbidity (aRR 0.83, 95% CI 0.59 to 1.17, 18 studies, 3696 participants, low-certainty evidence). Four studies reported data for 480 women comparing membrane sweeping with vaginal/intracervical prostaglandins There may be little to no difference between groups for the outcomes: · spontaneous onset of labour (aRR, 1.24, 95% CI 0.98 to 1.57, 3 studies, 339 participants, low-certainty evidence); · induction (aRR 0.90, 95% CI 0.56 to 1.45, 2 studies, 157 participants, low-certainty evidence); · caesarean (aRR 0.69, 95% CI 0.44 to 1.09, 3 studies, 339 participants, low-certainty evidence); · spontaneous vaginal birth (aRR 1.12, 95% CI 0.95 to 1.32, 2 studies, 252 participants, low-certainty evidence); · maternal death or serious morbidity (aRR 0.93, 95% CI 0.27 to 3.21, 1 study, 87 participants, low-certainty evidence); · neonatal perinatal death or serious morbidity (aRR 0.40, 95% CI 0.12 to 1.33, 2 studies, 269 participants, low-certainty evidence). One study, reported data for 104 women, comparing membrane sweeping with intravenous oxytocin +/- amniotomy There may be little to no difference between groups for: · spontaneous onset of labour (aRR 1.32, 95% CI 88 to 1.96, 1 study, 69 participants, low-certainty evidence); · induction (aRR 0.51, 95% CI 0.05 to 5.42, 1 study, 69 participants, low-certainty evidence); · caesarean (aRR 0.69, 95% CI 0.12 to 3.85, 1 study, 69 participants, low-certainty evidence); · maternal death or serious morbidity was reported on, but there were no events. Two studies providing data for 160 women compared membrane sweeping with vaginal/oral misoprostol There may be little to no difference between groups for: · caesareans (RR 0.82, 95% CI 0.31 to 2.17, 1 study, 96 participants, low-certainty evidence). One study providing data for 355 women which compared once weekly membrane sweep with twice-weekly membrane sweep and a sham procedure There may be little to no difference between groups for: · induction (RR 1.19, 95% CI 0.76 to 1.85, 1 study, 234 participants, low-certainty); · caesareans (RR 0.93, 95% CI 0.60 to 1.46, 1 study, 234 participants, low-certainty evidence); · spontaneous vaginal birth (RR 1.00, 95% CI 0.86 to 1.17, 1 study, 234 participants, moderate-certainty evidence); · maternal death or serious maternal morbidity (RR 0.78, 95% CI 0.30 to 2.02, 1 study, 234 participants, low-certainty evidence); · neonatal death or serious neonatal perinatal morbidity (RR 2.00, 95% CI 0.18 to 21.76, 1 study, 234 participants, low-certainty evidence); We found no studies that compared membrane sweeping with amniotomy only or mechanical methods. Three studies, providing data for 675 women, reported that women indicated favourably on their experience of membrane sweeping with one study reporting that 88% (n = 312) of women questioned in the postnatal period would choose membrane sweeping in the next pregnancy. Two studies reporting data for 290 women reported that membrane sweeping is more cost-effective than using prostaglandins, although more research should be undertaken in this area. Membrane sweeping may be effective in achieving a spontaneous onset of labour, but the evidence for this was of low certainty. When compared to expectant management, it potentially reduces the incidence of formal induction of labour. Questions remain as to whether there is an optimal number of membrane sweeps and timings and gestation of these to facilitate induction of labour.

Sections du résumé

BACKGROUND
Induction of labour involves stimulating uterine contractions artificially to promote the onset of labour. There are several pharmacological, surgical and mechanical methods used to induce labour. Membrane sweeping is a mechanical technique whereby a clinician inserts one or two fingers into the cervix and using a continuous circular sweeping motion detaches the inferior pole of the membranes from the lower uterine segment. This produces hormones that encourage effacement and dilatation potentially promoting labour. This review is an update to a review first published in 2005.
OBJECTIVES
To assess the effects and safety of membrane sweeping for induction of labour in women at or near term (≥ 36 weeks' gestation).
SEARCH METHODS
We searched Cochrane Pregnancy and Childbirth's Trials Register (25 February 2019), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (25 February 2019), and reference lists of retrieved studies.
SELECTION CRITERIA
Randomised and quasi-randomised controlled trials comparing membrane sweeping used for third trimester cervical ripening or labour induction with placebo/no treatment or other methods listed on a predefined list of labour induction methods. Cluster-randomised trials were eligible, but none were identified.
DATA COLLECTION AND ANALYSIS
Two review authors independently assessed studies for inclusion, risk of bias and extracted data. Data were checked for accuracy. Disagreements were resolved by discussion, or by including a third review author. The certainty of the evidence was assessed using the GRADE approach.
MAIN RESULTS
We included 44 studies (20 new to this update), reporting data for 6940 women and their infants. We used random-effects throughout. Overall, the risk of bias was assessed as low or unclear risk in most domains across studies. Evidence certainty, assessed using GRADE, was found to be generally low, mainly due to study design, inconsistency and imprecision. Six studies (n = 1284) compared membrane sweeping with more than one intervention and were thus included in more than one comparison. No trials reported on the outcomes uterine hyperstimulation with/without fetal heart rate (FHR) change, uterine rupture or neonatal encephalopathy. Forty studies (6548 participants) compared membrane sweeping with no treatment/sham Women randomised to membrane sweeping may be more likely to experience: · spontaneous onset of labour (average risk ratio (aRR) 1.21, 95% confidence interval (CI) 1.08 to 1.34, 17 studies, 3170 participants, low-certainty evidence). but less likely to experience: · induction (aRR 0.73, 95% CI 0.56 to 0.94, 16 studies, 3224 participants, low-certainty evidence); There may be little to no difference between groups for: · caesareans (aRR 0.94, 95% CI 0.85 to 1.04, 32 studies, 5499 participants, moderate-certainty evidence); · spontaneous vaginal birth (aRR 1.03, 95% CI 0.99 to 1.07, 26 studies, 4538 participants, moderate-certainty evidence); · maternal death or serious morbidity (aRR 0.83, 95% CI 0.57 to 1.20, 17 studies, 2749 participants, low-certainty evidence); · neonatal perinatal death or serious morbidity (aRR 0.83, 95% CI 0.59 to 1.17, 18 studies, 3696 participants, low-certainty evidence). Four studies reported data for 480 women comparing membrane sweeping with vaginal/intracervical prostaglandins There may be little to no difference between groups for the outcomes: · spontaneous onset of labour (aRR, 1.24, 95% CI 0.98 to 1.57, 3 studies, 339 participants, low-certainty evidence); · induction (aRR 0.90, 95% CI 0.56 to 1.45, 2 studies, 157 participants, low-certainty evidence); · caesarean (aRR 0.69, 95% CI 0.44 to 1.09, 3 studies, 339 participants, low-certainty evidence); · spontaneous vaginal birth (aRR 1.12, 95% CI 0.95 to 1.32, 2 studies, 252 participants, low-certainty evidence); · maternal death or serious morbidity (aRR 0.93, 95% CI 0.27 to 3.21, 1 study, 87 participants, low-certainty evidence); · neonatal perinatal death or serious morbidity (aRR 0.40, 95% CI 0.12 to 1.33, 2 studies, 269 participants, low-certainty evidence). One study, reported data for 104 women, comparing membrane sweeping with intravenous oxytocin +/- amniotomy There may be little to no difference between groups for: · spontaneous onset of labour (aRR 1.32, 95% CI 88 to 1.96, 1 study, 69 participants, low-certainty evidence); · induction (aRR 0.51, 95% CI 0.05 to 5.42, 1 study, 69 participants, low-certainty evidence); · caesarean (aRR 0.69, 95% CI 0.12 to 3.85, 1 study, 69 participants, low-certainty evidence); · maternal death or serious morbidity was reported on, but there were no events. Two studies providing data for 160 women compared membrane sweeping with vaginal/oral misoprostol There may be little to no difference between groups for: · caesareans (RR 0.82, 95% CI 0.31 to 2.17, 1 study, 96 participants, low-certainty evidence). One study providing data for 355 women which compared once weekly membrane sweep with twice-weekly membrane sweep and a sham procedure There may be little to no difference between groups for: · induction (RR 1.19, 95% CI 0.76 to 1.85, 1 study, 234 participants, low-certainty); · caesareans (RR 0.93, 95% CI 0.60 to 1.46, 1 study, 234 participants, low-certainty evidence); · spontaneous vaginal birth (RR 1.00, 95% CI 0.86 to 1.17, 1 study, 234 participants, moderate-certainty evidence); · maternal death or serious maternal morbidity (RR 0.78, 95% CI 0.30 to 2.02, 1 study, 234 participants, low-certainty evidence); · neonatal death or serious neonatal perinatal morbidity (RR 2.00, 95% CI 0.18 to 21.76, 1 study, 234 participants, low-certainty evidence); We found no studies that compared membrane sweeping with amniotomy only or mechanical methods. Three studies, providing data for 675 women, reported that women indicated favourably on their experience of membrane sweeping with one study reporting that 88% (n = 312) of women questioned in the postnatal period would choose membrane sweeping in the next pregnancy. Two studies reporting data for 290 women reported that membrane sweeping is more cost-effective than using prostaglandins, although more research should be undertaken in this area.
AUTHORS' CONCLUSIONS
Membrane sweeping may be effective in achieving a spontaneous onset of labour, but the evidence for this was of low certainty. When compared to expectant management, it potentially reduces the incidence of formal induction of labour. Questions remain as to whether there is an optimal number of membrane sweeps and timings and gestation of these to facilitate induction of labour.

Identifiants

pubmed: 32103497
doi: 10.1002/14651858.CD000451.pub3
pmc: PMC7044809
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD000451

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Références

J Coll Physicians Surg Pak. 2006 May;16(5):347-50
pubmed: 16756780
Obstet Gynecol. 1990 Oct;76(4):678-80
pubmed: 2216203
Br J Obstet Gynaecol. 1998 Jan;105(1):41-4
pubmed: 9442160
Cochrane Database Syst Rev. 2014 Jun 13;(6):CD001338
pubmed: 24924489
Acta Obstet Gynecol Scand. 1989;68(8):683-7
pubmed: 2698591
Ginekol Pol. 2014 Sep;85(9):682-7
pubmed: 25322540
Int J Gynaecol Obstet. 2004 Sep;86(3):388-9
pubmed: 15325859
Gynecol Obstet Invest. 2000;49(4):240-3
pubmed: 10828706
Gynecol Obstet Invest. 2006;62(1):41-4
pubmed: 16534210
J Reprod Med. 1977 Sep;19(3):125-7
pubmed: 894653
J Reprod Med. 1990 Aug;35(8):811-4
pubmed: 2213744
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007707
pubmed: 23450578
Am J Obstet Gynecol. 1993 Jul;169(1):71-7
pubmed: 8333480
Obstet Gynecol. 1964 Aug;24:266-8
pubmed: 14199536
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD000451
pubmed: 15674873
Acta Obstet Gynecol Scand. 2010 Aug;89(8):1003-10
pubmed: 20636240
BJOG. 2002 Jun;109(6):632-6
pubmed: 12118640
Obstet Gynecol. 2009 Oct;114(4):745-751
pubmed: 19888030
CMAJ. 1999 Apr 20;160(8):1145-9
pubmed: 10234344
J Obstet Gynaecol. 2002 May;22(3):283-6
pubmed: 12521500
J Perinatol. 1999 Mar;19(2):88-91
pubmed: 10642965
Eur J Obstet Gynecol Reprod Biol. 1996 Jun;66(2):129-32
pubmed: 8735733
Obstet Gynecol. 2006 Mar;107(3):569-77
pubmed: 16507926
Obstet Gynecol. 2000 Oct;96(4):539-42
pubmed: 11004355
Arch Gynecol Obstet. 2014 Jan;289(1):29-34
pubmed: 23764933
Acta Obstet Gynecol Scand. 2008;87(2):247-9
pubmed: 18240379
Obstet Gynecol. 1996 Jun;87(6):927-31
pubmed: 8649700
Obstet Gynecol. 1997 Apr;89(4):586-90
pubmed: 9083317
Obstet Gynecol. 2014 Aug;124(2 Pt 1):390-396
pubmed: 25050770
Obstet Gynecol. 1996 May;87(5 Pt 1):767-70
pubmed: 8677083
Obstet Gynecol. 2008 Jun;111(6):1313-9
pubmed: 18515514
Cochrane Database Syst Rev. 2001;(2):CD000451
pubmed: 11405964
J Clin Diagn Res. 2015 Aug;9(8):QC01-3
pubmed: 26435999
Ann Intern Med. 2009 Aug 18;151(4):252-63, W53-63
pubmed: 19687492
J Perinat Med. 2013 Sep 1;41(5):555-60
pubmed: 23612695
J Matern Fetal Med. 1997 Mar-Apr;6(2):71-8
pubmed: 9086420
Cochrane Database Syst Rev. 2000;(4):CD002862
pubmed: 11034776
Int J Gynaecol Obstet. 1998 Feb;60(2):115-21
pubmed: 9509948
Health Technol Assess. 2016 Aug;20(65):1-584
pubmed: 27587290
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006971
pubmed: 18254122
Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-397
pubmed: 19623003
BMJ Open. 2015 Sep 02;5(9):e008755
pubmed: 26338687
Am J Obstet Gynecol. 1998 Jun;178(6):1279-87
pubmed: 9662313
Br J Obstet Gynaecol. 1993 Oct;100(10):898-903
pubmed: 8217970
Cochrane Database Syst Rev. 2019 Oct 18;10:CD001233
pubmed: 31623014
Am J Obstet Gynecol. 2003 Jul;189(1):222-7
pubmed: 12861166
Am J Obstet Gynecol. 1998 Oct;179(4):890-4
pubmed: 9790365
Br J Obstet Gynaecol. 1998 Jan;105(1):34-40
pubmed: 9442159
Cochrane Database Syst Rev. 2018 May 09;5:CD004945
pubmed: 29741208
J Med Assoc Thai. 1999 Mar;82(3):229-33
pubmed: 10410476
J Matern Fetal Neonatal Med. 2015 Jul;28(10):1214-8
pubmed: 25082072
BJOG. 2006 Apr;113(4):402-8
pubmed: 16489935
Obstet Gynecol. 1958 Jan;11(1):74-8
pubmed: 13504633
BJOG. 2014 May;121(6):674-85; discussion 685
pubmed: 23834460
Int J Womens Health. 2011;3:287-94
pubmed: 21892340
BMJ Open. 2014 Aug 14;4(8):e005785
pubmed: 25125480
J Reprod Med. 2001 Aug;46(8):706-8
pubmed: 11547642
Br J Obstet Gynaecol. 1992 Jun;99(6):455-8
pubmed: 1637758
J Matern Fetal Neonatal Med. 2010 Jul;23(7):681-7
pubmed: 19895357

Auteurs

Elaine M Finucane (EM)

University Maternity Hospital Limerick, Ennis Road, Limerick, Ireland.

Deirdre J Murphy (DJ)

University of Dublin, Department of Obstetrics and Gynaecology Trinity College, Coombe Women's Hospital, Dolphin's Barn, Dublin 8, Ireland.

Linda M Biesty (LM)

National University of Ireland Galway, School of Nursing and Midwifery, Aras Moyola, Galway, Ireland.

Gillian Ml Gyte (GM)

University of Liverpool, Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health, First Floor, Liverpool Women's NHS Foundation Trust, Crown Street, Liverpool, UK, L8 7SS.

Amanda M Cotter (AM)

University of Limerick, Department of Obstetrics and Gynaecology, Limerick, Ireland.

Ethel M Ryan (EM)

Galway University, Maternity Department, Saolta Women's and Children's Directorate, Newcastle Road, Galway, Ireland.

Michel Boulvain (M)

University of Geneva/GHOL-Nyon Hospital, Department of Gynecology and Obstetrics, NYON, Switzerland.

Declan Devane (D)

National University of Ireland Galway, School of Nursing and Midwifery, Aras Moyola, Galway, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH